Statistics for Phoenix Biotech Acquisition (id:6883 PBAX)
Valuation metrics
Market cap
36.47M
Enterprise value
37.82M
Trailing P/E (ttm)
-7.27
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
-0.25
Enterprise Value/Revenue
Enterprise Value/EBITDA
-6.59
Overview
Shares outstanding
6.23M
Float
940.12K
Shares short
757.00
% Held by insiders
0.95%
% Held by institutions
0.15%
Average volume (10 days)
39.10K
Average volume (90 days)
Price summary
52-Week low
0.06
52-Week high
12.80
52-Week change
-4,886.24%
Beta
0.04
50-Day moving average
10.39
200-Day moving average
10.74
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2022
Most recent quarter (mrq)
September 30th, 2023
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-2.55%
Return on equity
-27.05%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-2,516,148.00
Diluted EPS (ttm)
-0.35
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
119.01K
Total cash per share (mrq)
0.02
Total debt (mrq)
1.40M
Total Debt/Equity (mrq)
-0.25
Current ratio (mrq)
176.40%
Book value per share (mrq)
-2.20
Cash flow
Cash flow statement
-1,710,095.00
Levered free cash flow (LFCF)
-7,951,432.00